OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
27 Juni 2023 - 2:07PM
OrthoPediatrics Corp. (“OrthoPediatrics” or the
“Company”) (Nasdaq: KIDS), a company focused exclusively on
advancing the field of pediatric orthopedics, today announced the
limited launch and the completion of the first clinical case using
the new GIRO Growth Modulation System.
The GIRO tether device is indicated for
pediatric patients to aid in the correction of angular deformities
of long bones and limb length discrepancy. Two configurations of
the system are available, the GIRO Screw configuration for
deformities in the femur and tibia, humerus, radius and ulna or
ankle and the GIRO Post configuration for limb length discrepancy
of the femur and tibia. The GIRO Growth Modulation system
represents the first new Pega Medical system to receive FDA
clearance and be launched under OrthoPediatrics and the company’s
50th system for pediatric orthopedic care.
The first case was completed last week to treat
a patient’s bilateral femoral anteversion without additional
osteotomy, making this a less invasive procedure with shorter
recovery time and less risk of complications. The low profile
implants make GIRO a versatile tethering system and an attractive
option for treating patients’ angular deformities and limb length
discrepancies moving forward.
Joe Hauser, President of Trauma and Deformity
Correction at OrthoPediatrics, added, “The first clinical case with
the GIRO Growth Modulation system represents a milestone for our
business as we continue to leverage the technology and expertise of
our colleagues at OrthoPediatrics Canada. This system provides our
pediatric orthopedic surgeon partners with a new option to treat
their patients, we are excited to see this technology improve the
care of kids.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an orthopedic
company focused exclusively on advancing the field of pediatric
orthopedics. As such it has developed the most comprehensive
product offering to the pediatric orthopedic market to improve the
lives of children with orthopedic conditions. OrthoPediatrics
currently markets 50 surgical systems that serve three of the
largest categories within the pediatric orthopedic market. This
product offering spans trauma and deformity, scoliosis, and sports
medicine/other procedures. OrthoPediatrics’ global sales
organization is focused exclusively on pediatric orthopedics and
distributes its products in the United States and over 70 countries
outside the United States. For more information, please visit
www.orthopediatrics.com.
Investor ContactPhilip Trip TaylorGilmartin
Groupphilip@gilmartinir.com415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
OrthoPediatrics (NASDAQ:KIDS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024